🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT07526103
Starting soon Not applicable

Developing a Colonoscopy Preparation Protocol for Patients With Diabetes

NCT07526103 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-06-01
Last updated
2026-04-24

Condition(s) studied

HypoglycaemiaDiabete MellitusColonoscopy (Ambulatory Patients)

Investigational drug(s) / intervention(s)

timing of cleansing and procedure

timing of cleansing and procedure: we are altering the timing of colonoscopy and cleansing for colonoscopy for patients with diabetes.

Study summary

Patients with diabetes have less effective colonoscopy preparation when compared to nondiabetic patients. This leads to the possibility of missed polyps, longer procedural time and patient dissatisfaction. Furthermore, the peri-colonoscopy period has been associated with increased risk of hypoglycemic events given the required change in diet and possible changes in antihyperglycemic medication regime, though this area is not well studied.

Studies have found that same day preparation for colonoscopy allowed for comparable bowel visualization to split dosing. Pairing this with a low fiber diet permitted the day prior to colonoscopy, the extent of changes to routine and diet within a patient with diabetes day for colonoscopy preparation is minimized and could reduce risk of side effects and hypoglycemia, while also ensuring adequate bowel preparation.

This study tests the hypothesis that creating a diabetic specific protocol (permitting a low fibre diet the day prior to colonoscopy and using same day preparation) will result in fewer hypoglycemic events and more adequate quality preparation in comparison to a conventional 2L PEG split day preparation with dietary restrictions in patients with diabetes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients Age over the age of 18 2. Able to read and understand the English language 3. Confirmed diagnosis of diabetes (Type 1 or Type 2) Exclusion Criteria: 1. Patients without diabetes 2. Patients with prior hospital admission due to hypoglycemic events 3. Patients who have inflammatory bowel disease 4. Patients with ileus or bowel obstruction 5. Patients with history of colorectal resection 6. Patients receiving combined upper and lower endoscopies 7. Patients with ascites 8. Patients with previously documented severe renal impairment 9. Unable to provide consent 10. Pregnant or lactating female (females of child-bearing potential will undergo urine pregnancy testing) 11. Patients who have had a recent myocardial infarction(\<6months) 12. Allergy to product ingredients

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kingston Health Sciences Centre Kingston Ontario

More Queen's University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07526103 on ClinicalTrials.gov ↗ ← All trials in Canada